Xylem misses Q3 revenue by $80M, EPS below estimates, sparking securities law probe.

Xylem Inc. reported third-quarter revenue of approximately $2.20 billion, missing Wall Street's estimate by about $80 million and falling short of its own projections. Adjusted earnings per share were $1.44, slightly below the consensus of $1.45. The company cited project delays and cautious customer spending as reasons for the shortfall and lowered its full-year revenue forecast to around $8.95 billion from $9.2 billion. Following the disappointing results, a securities law investigation has been launched to determine if Xylem made misleading statements that harmed shareholders. Investors who suffered losses are encouraged to submit their information for a potential recovery review.

Xylem Inc.'s stock price on Pluang has dropped sharply by 13.80% to USD 93.30, reflecting significant investor reaction. As of Oct 28, 2026 09:41 WIB, the stock shows a market cap of $25.27 billion and a high buy interest with 97% of orders on Pluang being buys.